Spearhead Capital Advisors, LLC Ptc Therapeutics, Inc. Transaction History

Spearhead Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$25.6 - $45.23 $2,688 - $4,749	-105 Reduced 1.39%	7,448 $298,000
Q1 2022 Apr 28, 2022	SELL	$33.33 - $44.6 $17,098 - $22,879	-513 Reduced 6.36%	7,553 $282,000
Q4 2021 Jan 25, 2022	BUY	$35.36 - $41.86 $4,950 - $5,860	140 Added 1.77%	8,066 $321,000
Q3 2021 Oct 27, 2021	SELL	$37.01 - $44.74 $1,332 - $1,610	-36 Reduced 0.45%	7,926 $295,000
Q2 2021 Aug 10, 2021	BUY	$37.95 - $49.37 $55,520 - $72,228	1,463 Added 22.51%	7,962 $337,000
Q1 2021 Apr 28, 2021	BUY	$46.8 - $68.92 $304,153 - $447,911	6,499 New	6,499 $308,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.27B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Spearhead Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Spearhead Capital Advisors, LLC with notifications on news.